AP NEWS

Bristol-Myers Squibb to Take Part in Goldman Sachs 39th Annual Global Healthcare Conference

June 11, 2018

NEW YORK--(BUSINESS WIRE)--Jun 11, 2018--Bristol-Myers Squibb Company (NYSE: BMY) will take part in Goldman Sachs 39 th Annual Global Healthcare Conference on Wednesday, June 13, 2018, in Rancho Palos Verdes, CA. Johanna Mercier, Head of U.S. Commercial, and Fouad Namouni, Head of Oncology Development, will answer questions about the company at 6:20 p.m. ET (3:20 p.m. PT).

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at  BMS.com  or follow us on LinkedInTwitter, YouTube and Facebook.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180611006205/en/

CONTACT: Bristol-Myers Squibb

Media:

Ken Dominski, 609-252-5251

ken.dominski@bms.com

or

Investors:

Tim Power, 609-252-7509

timothy.power@bms.com

or

Bill Szablewski, 609-252-5894

william.szablewski@bms.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA NEW YORK

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY ONCOLOGY PHARMACEUTICAL GENERAL HEALTH

SOURCE: Bristol-Myers Squibb Company

Copyright Business Wire 2018.

PUB: 06/11/2018 04:45 PM/DISC: 06/11/2018 04:45 PM

http://www.businesswire.com/news/home/20180611006205/en

AP RADIO
Update hourly